MARKET

NHWK

NHWK

NightHawk
AMEX
1.850
+0.080
+4.52%
After Hours: 1.860 +0.01 +0.54% 18:32 10/04 EDT
OPEN
1.750
PREV CLOSE
1.770
HIGH
1.900
LOW
1.750
VOLUME
37.40K
TURNOVER
0
52 WEEK HIGH
6.09
52 WEEK LOW
1.600
MARKET CAP
47.47M
P/E (TTM)
-1.1946
1D
5D
1M
3M
1Y
5Y
'NightHawk Biosciences (formerly Heat Biologics) has received a Notice of Allowance for its US patent application 16/497,672 titled "INTRATUMORAL VACCINATION (FOR THE TREATMENT OF TUMORS)' - PatentGrants
https://twitter.com/PatentGrants/status/1568265493496365056   https://patentcenter.uspto.gov/applications/16497672/ifw/docs 
Benzinga · 09/09 15:54
Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday
Gainers
Benzinga · 08/24 09:56
BRIEF-NightHawk Biosciences Announces Buildout Of Advanced Biosafety Level 2 Laboratory
BRIEF-NightHawk Biosciences Announces Buildout Of Advanced Biosafety Level 2 Laboratory
Reuters · 08/23 11:36
Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of any developments that would explain the recent surge.
Benzinga · 08/23 10:11
NHWK: Scorpion Grand Opening 3Q:22
By John Vandermosten, CFA NYSE:NHWK READ THE FULL NHWK RESEARCH REPORT
Benzinga · 08/22 14:33
Why NightHawk Biosciences Stock Is Soaring
NightHawk Biosciences Inc (AMEX:NHWK) shares are trading higher Monday after the company said it would fund development of a monkeypox vaccine.
Benzinga · 08/22 13:12
Nighthawk Biosciences rises 21% on monkeypox vaccine R&D agreement
Nighthawk Biosciences (NYSE:NHWK) is up ...
Seekingalpha · 08/22 12:50
AXSM, NHWK and VERU are among pre market gainers
SaverOne (SVRE) +63%. XORTX Therapeutics (<a href="https://seekingalp...
Seekingalpha · 08/22 12:20
More
About NHWK
NightHawk Biosciences, Inc., formerly Heat Biologics, Inc., is a fully integrated biopharmaceutical company. The Company specializes in the end-to-end development and commercialization of therapies that arm the immune system against a range of diseases including cancer and infectious disease. It focuses on drug development through its integrated ecosystem of subsidiary companies, which includes Skunkworx Bio (Skunkworx), Heat Biologics (Heat), Pelican Therapeutics (Pelican), Scorpion Biological Services (Scorpion) and Elusys Therapeutics (Elusys). It offers three technology platform, namely gp96, which leverages the immune stimulatory properties of the heat shock protein gp96 to induce the immune system’s own response against cancer and infectious disease; TNFRSF25, which targets the T cell co-stimulator TNFRSF25 to regulate inflammation and immunosuppression, and RapidVax designed to induce immunological memory against emerging biological threats and accelerate timeline to the clinic.

Webull offers kinds of NightHawk Biosciences Inc stock information, including AMEX:NHWK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NHWK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NHWK stock methods without spending real money on the virtual paper trading platform.